Akeso, Inc. (AKESF)
7.85
-0.31
(-3.80%)
USD |
OTCM |
Nov 17, 16:00
Akeso Price to Book Value : 116.06 for Nov. 17, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 17, 2026 | 116.06 |
| November 16, 2026 | 120.64 |
| November 13, 2026 | 152.20 |
| November 12, 2026 | 157.53 |
| November 11, 2026 | 169.28 |
| November 10, 2026 | 169.28 |
| November 09, 2026 | 169.28 |
| November 06, 2026 | 158.04 |
| November 05, 2026 | 153.46 |
| November 04, 2026 | 155.09 |
| November 03, 2026 | 147.84 |
| November 02, 2026 | 151.54 |
| October 30, 2026 | 162.63 |
| October 29, 2026 | 162.63 |
| October 28, 2026 | 156.80 |
| October 27, 2026 | 155.23 |
| October 26, 2026 | 158.93 |
| October 23, 2026 | 160.41 |
| October 22, 2026 | 160.26 |
| October 21, 2026 | 179.42 |
| October 20, 2026 | 179.42 |
| October 19, 2026 | 169.72 |
| October 16, 2026 | 166.32 |
| October 15, 2026 | 166.32 |
| October 14, 2026 | 177.41 |
| Date | Value |
|---|---|
| October 13, 2026 | 194.41 |
| October 12, 2026 | 215.01 |
| October 09, 2026 | 215.01 |
| October 08, 2026 | 204.02 |
| October 07, 2026 | 204.02 |
| October 06, 2026 | 203.28 |
| October 05, 2026 | 203.28 |
| October 02, 2026 | 198.70 |
| October 01, 2026 | 200.55 |
| September 30, 2026 | 196.41 |
| September 29, 2026 | 192.19 |
| September 28, 2026 | 186.28 |
| September 25, 2026 | 186.28 |
| September 24, 2026 | 184.80 |
| September 23, 2026 | 175.19 |
| September 22, 2026 | 182.58 |
| September 21, 2026 | 186.72 |
| September 18, 2026 | 169.72 |
| September 17, 2026 | 168.91 |
| September 16, 2026 | 173.86 |
| September 15, 2026 | 181.40 |
| September 14, 2026 | 182.58 |
| September 11, 2026 | 174.45 |
| September 10, 2026 | 183.92 |
| September 09, 2026 | 183.92 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Ascletis Pharma, Inc. | 5.625 |
| CStone Pharmaceuticals Co. Ltd. | 9.728 |
| RemeGen Co., Ltd. | 4.21 |
| InnoCare Pharma Ltd. | 2.313 |
| Adagene, Inc. | -- |
Price to Book Value Related Metrics
| PS Ratio | 14.54 |
| PEG Ratio | -2.097 |
| Price | 7.85 |
| Earnings Yield | -1.92% |
| Market Cap | 7.211B |
| PEGY Ratio | -2.097 |